Send to

Choose Destination
See comment in PubMed Commons below
Autoimmun Rev. 2009 Jul;8(8):650-3. doi: 10.1016/j.autrev.2009.02.013. Epub 2009 Feb 12.

Myelin peptides in multiple sclerosis.

Author information

  • 1Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.


The development of specific therapies for organ-specific autoimmune diseases requires the identification of relevant immunogenic epitopes, recognized by both pathogenic T cells and autoantibodies. Here, we review the most relevant studies focused in the identification of peptides in multiple sclerosis (MS) and the distinct T cell reactivity induced in patients compared to controls. Only a few studies reported significant differences in terms of T cell reactivity to them. The current knowledge on this issue, and the diagnostic and therapeutic possibilities opened by the identification of pathogenic MS epitopes are discussed in this paper.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk